Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study
J. Clin. Oncol 2020 Jul 02;[EPub Ahead of Print], C Zhou, X Li, Q Wang, G Gao, Y Zhang, J Chen, Y Shu, Y Hu, Y Fan, J Fang, G Chen, J Zhao, J He, F Wu, J Zou, X Zhu, X LinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.